RIT1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.97619714931352E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.920699999991E-05 |
Normal-vs-Stage2 |
8.442300E-03 |
Normal-vs-Stage3 |
9.580800E-03 |
Normal-vs-Stage4 |
4.029900E-02 |
Stage1-vs-Stage2 |
4.364200E-01 |
Stage1-vs-Stage3 |
2.406200E-01 |
Stage1-vs-Stage4 |
7.729600E-02 |
Stage2-vs-Stage3 |
6.368200E-01 |
Stage2-vs-Stage4 |
3.538200E-01 |
Stage3-vs-Stage4 |
6.611200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.94870017292226E-10 |
Normal-vs-AfricanAmerican |
2.437600E-04 |
Normal-vs-Asian |
5.782200E-01 |
Caucasian-vs-AfricanAmerican |
2.170000E-01 |
Caucasian-vs-Asian |
3.846000E-01 |
AfricanAmerican-vs-Asian |
4.907200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.05509999626108E-08 |
Normal-vs-Female |
1.16959999996169E-06 |
Male-vs-Female |
2.126200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
4.235400E-03 |
Normal-vs-Extreme_Weight |
5.164200E-04 |
Normal-vs-Obese |
4.47690000000556E-05 |
Normal-vs-Extreme_Obese |
7.156500E-02 |
Normal_Weight-vs-Extreme_Weight |
5.086800E-01 |
Normal_Weight-vs-Obese |
7.920600E-01 |
Normal_Weight-vs-Extreme_Obese |
8.731200E-01 |
Extreme_Weight-vs-Obese |
6.262400E-01 |
Extreme_Weight-vs-Extreme_Obese |
5.472000E-01 |
Obese-vs-Extreme_Obese |
6.809400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
2.881600E-02 |
Normal-vs-Age(41-60Yrs) |
2.02630023871109E-10 |
Normal-vs-Age(61-80Yrs) |
2.26439999999606E-05 |
Normal-vs-Age(81-100Yrs) |
3.680400E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.365300E-04 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.481900E-02 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.964000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.123500E-02 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.339700E-02 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.461600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-VS-Type1 PRCC |
2.85229617702498E-11 |
Normal-VS-Type2 PRCC |
1.381650E-03 |
Normal-VS-KIRP CIMP |
7.542000E-01 |
Normal-VS-Unclassified PRCC |
9.299100E-03 |
Type1 PRCC-VS-Type2 PRCC |
5.697600E-01 |
Type1 PRCC-VS-KIRP CIMP |
8.064200E-02 |
Type1 PRCC-VS-Unclassified PRCC |
5.301200E-01 |
Type2 PRCC-VS-KIRP CIMP |
2.883800E-01 |
Type2 PRCC-VS-Unclassified PRCC |
9.434200E-01 |
KIRP CIMP-VS-Unclassified PRCC |
2.488400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
3.226700E-04 |
Normal-vs-N1 |
4.639200E-03 |
Normal-vs-N2 |
1.648430E-01 |
N0-vs-N1 |
2.238400E-01 |
N0-vs-N2 |
4.777900E-02 |
N1-vs-N2 |
2.376000E-02 |
|
|